Effect of Vitamin D Supplementation on Mycobacterium tuberculosis-Induced Innate Immune Responses in a Canadian Dené First Nations Cohort

por Larcombe, Linda, Orr, Pamela, Turner-Brannen, Emily, Slivinski, Caroline R., Nickerson, Peter W., Mookherjee, Neeloffer
Publicado 2012

A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation

por Nickerson, Peter W., Balshaw, Robert, Wiebe, Chris, Ho, Julie, Gibson, Ian W., Bridges, Nancy D., Rush, David N., Heeger, Peter S.
Publicado 2020

Prediction of Long-term Renal Allograft Outcome By Early Urinary CXCL10 Chemokine Levels

por Hirt-Minkowski, Patricia, Ho, Julie, Gao, Ang, Amico, Patrizia, Koller, Michael T., Hopfer, Helmut, Rush, David N., Nickerson, Peter W., Schaub, Stefan
Publicado 2015

Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10

por Ho, Julie, Sharma, Atul, Mandal, Rupasri, Wishart, David S., Wiebe, Chris, Storsley, Leroy, Karpinski, Martin, Gibson, Ian W., Nickerson, Peter W., Rush, David N.
Publicado 2016

The negative impact of T cell–mediated rejection on renal allograft survival in the modern era

por Rampersad, Christie, Balshaw, Robert, Gibson, Ian W., Ho, Julie, Shaw, Jamie, Karpinski, Martin, Goldberg, Aviva, Birk, Patricia, Rush, David N., Nickerson, Peter W., Wiebe, Chris
Publicado 2021

Premortem anticoagulation timing and dose in donation after circulatory death: multicentre study of associations with graft function

por Kramer, Andreas H., Holliday, Kerry, Keenan, Sean, Isac, George, Kutsogiannis, Demetrius J., Kneteman, Norman M., Kim, Peter, Robertson, Adrian, Nickerson, Peter W., Tibbles, Lee Anne
Publicado 2022

Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design

por Nickerson, Peter W., Böhmig, Georg A., Chadban, Steve, Kumar, Deepali, Mannon, Roslyn B., van Gelder, Teun, Lee, James C., Adler, Scott, Chong, Edward, Djamali, Arjang
Publicado 2022

HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity

por Wiebe, Chris, Kosmoliaptsis, Vasilis, Pochinco, Denise, Gibson, Ian W., Ho, Julie, Birk, Patricia E., Goldberg, Aviva, Karpinski, Martin, Shaw, Jamie, Rush, David N., Nickerson, Peter W.
Publicado 2018

Evidence for the alloimmune basis and prognostic significance of Borderline T cell–mediated rejection

por Wiebe, Chris, Rush, David N., Gibson, Ian W., Pochinco, Denise, Birk, Patricia E., Goldberg, Aviva, Blydt‐Hansen, Tom, Karpinski, Martin, Shaw, Jamie, Ho, Julie, Nickerson, Peter W.
Publicado 2020

Comparison of the effects of standard vs low‐dose prolonged‐release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts

por Cockfield, Sandra M., Wilson, Sam, Campbell, Patricia M., Cantarovich, Marcelo, Gangji, Azim, Houde, Isabelle, Jevnikar, Anthony M., Keough‐Ryan, Tammy M., Monroy‐Cuadros, Felix‐Mauricio, Nickerson, Peter W., Pâquet, Michel R., Ramesh Prasad, G. V., Senécal, Lynne, Shoker, Ahmed, Wolff, Jean‐Luc, Howell, John, Schwartz, Jason J., Rush, David N.
Publicado 2019